nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adherence to surveillance guidelines in resected NSCLC: Physician compliance and impact on outcomes
|
Ho, Cheryl |
|
2017 |
112 |
C |
p. 176-180 |
artikel |
2 |
Anamorelin for advanced non-small-cell lung cancer with cachexia: Systematic review and meta-analysis
|
Nishie, Kenichi |
|
2017 |
112 |
C |
p. 25-34 |
artikel |
3 |
Anaplastic lymphoma kinase gene rearrangement predicts better prognosis in NSCLC patients: A meta-analysis
|
Wang, Zili |
|
2017 |
112 |
C |
p. 1-9 |
artikel |
4 |
A phase II trial of carboplatin plus S-1 for elderly patients with advanced non-small-cell lung cancer with wild-type epidermal growth factor receptor: The Okayama Lung Cancer Study Group Trial 1202
|
Kuyama, Shoichi |
|
2017 |
112 |
C |
p. 188-194 |
artikel |
5 |
Circulating tumor cells as a predictive biomarker in patients with small cell lung cancer undergoing chemotherapy
|
Aggarwal, Charu |
|
2017 |
112 |
C |
p. 118-125 |
artikel |
6 |
Clinical predictors of survival in young patients with small cell lung cancer: Results from the California Cancer Registry
|
Lara, Joshua D. |
|
2017 |
112 |
C |
p. 165-168 |
artikel |
7 |
Clinical significance of tumor cavitation in surgically resected early-stage primary lung cancer
|
Tomizawa, Kenji |
|
2017 |
112 |
C |
p. 57-61 |
artikel |
8 |
Contents
|
|
|
2017 |
112 |
C |
p. iv-vi |
artikel |
9 |
Corrigendum to: ‘Gender difference in human papillomarvirus infection for non-small cell lung cancer in Taiwan’ [Lung Cancer 46 (November(2)) (2004) 165–170]
|
Cheng, Ya-Wen |
|
2017 |
112 |
C |
p. 232-233 |
artikel |
10 |
Does timeliness of care in Non-Small Cell Lung Cancer impact on survival?
|
Vinod, Shalini K. |
|
2017 |
112 |
C |
p. 16-24 |
artikel |
11 |
Editorial Board
|
|
|
2017 |
112 |
C |
p. iii |
artikel |
12 |
Fine-mapping the MHC region in Asian populations identified novel variants modifying susceptibility to lung cancer
|
Qin, Na |
|
2017 |
112 |
C |
p. 169-175 |
artikel |
13 |
Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation
|
Hsieh, Feng-Shu |
|
2017 |
112 |
C |
p. 81-89 |
artikel |
14 |
Limited mutagenicity of electronic cigarettes in mouse or human cells in vitro
|
Tommasi, Stella |
|
2017 |
112 |
C |
p. 41-46 |
artikel |
15 |
LKB1/STK11 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value
|
Facchinetti, Francesco |
|
2017 |
112 |
C |
p. 62-68 |
artikel |
16 |
Marked response to pembrolizumab in a patient with pulmonary pleomorphic carcinoma highly positive for PD-L1
|
Ikematsu, Yuki |
|
2017 |
112 |
C |
p. 230-231 |
artikel |
17 |
MHC class II expression in lung cancer
|
He, Yayi |
|
2017 |
112 |
C |
p. 75-80 |
artikel |
18 |
Mig-6 deficiency cooperates with oncogenic Kras to promote mouse lung tumorigenesis
|
Liu, Jian |
|
2017 |
112 |
C |
p. 47-56 |
artikel |
19 |
Outcome of radical local treatment of non-small cell lung cancer patients with synchronous oligometastases
|
Kwint, Margriet |
|
2017 |
112 |
C |
p. 134-139 |
artikel |
20 |
Outcomes in patients with aggressive or refractory disease from REVEL: A randomized phase III study of docetaxel with ramucirumab or placebo for second-line treatment of stage IV non-small-cell lung cancer
|
Reck, Martin |
|
2017 |
112 |
C |
p. 181-187 |
artikel |
21 |
Patterns of care and survival among patients with malignant mesothelioma in the United States
|
Enewold, Lindsey |
|
2017 |
112 |
C |
p. 102-108 |
artikel |
22 |
PD-L1 expression in advanced NSCLC: Insights into risk stratification and treatment selection from a systematic literature review
|
Brody, Robert |
|
2017 |
112 |
C |
p. 200-215 |
artikel |
23 |
Phase 2 study of intermittent pulse dacomitinib in patients with advanced non-small cell lung cancers
|
Yu, Helena A. |
|
2017 |
112 |
C |
p. 195-199 |
artikel |
24 |
Phenotypes of lung cancer and statistical interactions between tobacco smoking and occupational exposure to asbestos and crystalline silica from a large case-only study: The CaProMat study
|
El Zoghbi, Mohamad |
|
2017 |
112 |
C |
p. 140-155 |
artikel |
25 |
PIK3CA mutation as a distinctive genetic feature of non-small cell lung cancer with chronic obstructive pulmonary disease: A comprehensive mutational analysis from a multi-institutional cohort
|
Sawa, Kenji |
|
2017 |
112 |
C |
p. 96-101 |
artikel |
26 |
Plasma concentration of osimertinib in a non-small cell lung cancer patient with chronic renal failure undergoing hemodialysis
|
Tamura, Tomohiro |
|
2017 |
112 |
C |
p. 225-226 |
artikel |
27 |
Prognostic value of HLA-A2 status in advanced non-small cell lung cancer patients
|
Mezquita, Laura |
|
2017 |
112 |
C |
p. 10-15 |
artikel |
28 |
Prospective analysis of patient reported symptoms and quality of life in patients with incurable lung cancer treated in a rapid access clinic
|
Lefresne, Shilo |
|
2017 |
112 |
C |
p. 35-40 |
artikel |
29 |
Response rates to single-agent chemotherapy after exposure to immune checkpoint inhibitors in advanced non-small cell lung cancer
|
Schvartsman, Gustavo |
|
2017 |
112 |
C |
p. 90-95 |
artikel |
30 |
Serum lipid profile discriminates patients with early lung cancer from healthy controls
|
Ros-Mazurczyk, Małgorzata |
|
2017 |
112 |
C |
p. 69-74 |
artikel |
31 |
The establishing of a new thoracic surgery department in Greece in the era of financial crisis
|
Kapetanakis, Emmanouil I. |
|
2017 |
112 |
C |
p. 227-229 |
artikel |
32 |
Timeliness of access to lung cancer diagnosis and treatment: A scoping literature review
|
Jacobsen, Margo M. |
|
2017 |
112 |
C |
p. 156-164 |
artikel |
33 |
Treatment, outcome and quality of life of 1239 patients with advanced non-small cell lung cancer – final results from the prospective German TLK cohort study
|
von Verschuer, Ulla |
|
2017 |
112 |
C |
p. 216-224 |
artikel |
34 |
Treatment outcomes by histology in REVEL: A randomized phase III trial of Ramucirumab plus docetaxel for advanced non-small cell lung cancer
|
Paz-Ares, Luis G. |
|
2017 |
112 |
C |
p. 126-133 |
artikel |
35 |
Wolf in Sheep’s Clothing: Primary Lung Cancer Mimicking Benign Entities
|
Snoeckx, Annemie |
|
2017 |
112 |
C |
p. 109-117 |
artikel |